Valion Bio Advances Integrated Biodefense and Immunology Platform Through Continued Government Engagement, Domestic Manufacturing and Oncology Expansion

Summary

Valion Bio announced strategic execution across multiple initiatives for its Entolimod platform, positioning it to pursue opportunities in government preparedness, domestic biomanufacturing, and oncology supportive care. The announcement reflects continued platform development and expansion efforts.